Scientific publications
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations
Mario Fernández-Ruiz 1 , Juan José Castón 2 , José Luis Del Pozo 3 , Jordi Carratalà 4 , Jesús Fortún 5 , Miguel Salavert 6 , Julián Torre-Cisneros 2 , José María Aguado 7 ; members of the OPENIN (Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones) Group; Ana Fernández Cruz 8 , Ana Ventura 9 , Belén Loeches 10 , Carlos Dueñas 11 , Cristina Tomás 12 , David Navarro 13 , Rosa Oltra 13 , Elena Resino-Foz 14 , Elisa García Vázquez 15 , Enrique Míguez 16 , Esperanza Merino 17 , Francisco Braojos 18 , Francisco Javier Martínez 19 , Francisco López-Medrano Pérez 20 , Isabel Machuca 21 , Javier Cobo 22 , Joaquín López Contreras 23 , José María Reguera 24 , Juan Diego Ruiz Mesa 24 , Juan Tiraboschi 25 , Lucy Abella 26 , Mar Masiá 27 , María Dolores Del Toro López 28 , María Dolores Díaz López 29 , Nerea Carrasco-Antón 30 , Nicolás Merchante 31 , Patricia Muñoz 32 , Rafael Torres 33 , Regino Rodríguez 34 , Tatiana Mata-Forte 35 , Vicente Abril 36
Abstract
Pneumonia continues to be one of the most frequent infectious syndromes and a relevant cause of death and health resources utilization. The OPENIN ("Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones") Group is composed of Infectious Diseases specialists and Microbiologists and aims at generating recommendations that can contribute to improve the approach to processes with high impact on the health system. Such task relies on a critical review of the available scientific evidence.
The first Group meeting (held in October 2023) aimed at answering the following questions: Can we optimize the syndromic and microbiological diagnosis of pneumonia? Is it feasible to safely shorten the length of antibiotic therapy? And, is there any role for the immunomodulatory strategies based on the adjuvant use of steroids, macrolides or immunoglobulins?
The present review summarizes the literature reviewed for that meeting and offers a series of expert recommendations.
CITATION Enferm Infecc Microbiol Clin (Engl Ed). 2024 Oct;42(8):442-452. doi: 10.1016/j.eimce.2024.07.001
Our authors
